Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Cellular/Molecular

Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization

Michael S. Virk, Seksiri Arttamangkul, William T. Birdsong and John T. Williams
Journal of Neuroscience 3 June 2009, 29 (22) 7341-7348; DOI: https://doi.org/10.1523/JNEUROSCI.3723-08.2009
Michael S. Virk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seksiri Arttamangkul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William T. Birdsong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John T. Williams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Buprenorphine hyperpolarized LC neurons and blocked the ME-induced hyperpolarization. Voltage recording made with intracellular electrodes. A, Buprenorphine (Bup; 1 μm) was applied for 15 min and caused a sustained hyperpolarization. Pressure ejection of ME (ME puff, arrows) caused a transient reproducible inhibition in spontaneous firing and hyperpolarization that was blocked by the application of buprenorphine. Application of orphanin FQ/nociception (OFQ) resulted in an additional hyperpolarization. B, ME (1 μm, 2 min) caused an inhibition of spontaneous firing and a hyperpolarization of ∼25 mV. Buprenorphine (200 nm) caused a hyperpolarization over a period of 25 min. The hyperpolarization induced by ME (1 μm) was decreased by buprenorphine, and, after 25 min, application of ME (30 μm) caused only a small hyperpolarization. Naloxone (Nal; 10 μm for 25 min) had little effect on the membrane potential. UK14304 (UK, 3 μm) caused a hyperpolarization of ∼35 mV. Yoh, Yohimbine.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Buprenorphine limits ME-induced desensitization. Voltage-clamp recordings made with whole-cell electrodes. A, A control experiment using an untreated slice. ME (30 μm) caused a large outward current that declined during the 10 min application period. B, An experiment taken from a slice that was preincubated with buprenorphine (Bup; 5 nm, 1 h). ME (30 μm) caused a small outward current that did not desensitize during the 10 min application. C, An experiment using a slice that was preincubated with β-CNA (20 nm, 1 h). ME (30 μm) caused a small outward current that desensitized during the 10 min application period. D, Summary of results, plotting the peak amplitude of the current induced by ME (30 μm) against the amount of desensitization (the change in current from the peak to the end of the 10 min application divided by the peak current). The open boxes (vertical line at 35%) indicate experiments done in control slices (A). The amount of desensitization was independent of the initial amplitude of current induced by ME. The gray circles (positive sloping line) are experiments done after buprenorphine (B). In this case, when the current induced by ME was larger, the amount of desensitization was greater. When the ME currents were smaller than 150 pA, the desensitization was eliminated. Filled triangles (negative sloping line) are experiments done after β-CNA (C). In this case, as the current induced by ME decreased, the amount of desensitization was increased.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Buprenorphine blocked desensitization induced by etorphine. A, A control experiment showing the desensitization induced by etorphine (1 μm), the reversal of the current induced by naloxone (Nal; 1 μm), and the current induced by UK14304 (UK; 3 μm). B, An experiment done in a slice that was incubated in buprenorphine (5 nm, 1 h). The current induced by etorphine (1 μm) is significantly smaller and did not desensitize during the 10 min application period. Yoh, Yohimbine.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Incubation of slices with etorphine, oxymorphone, methadone, or oxycodone did not block ME-induced desensitization. A, Sample experiment from a slice that was incubated with etorphine (2 nm, 1 h) before recording the outward current induced by ME (30 μm, 10 min). The ME current peaked (ME1) and declined (ME2) during the 10 min application period. Superfusion with naloxone (Nal; 1 μm) caused an inward current, indicating the presence of etorphine in the slice. B, The same experiment done with slices that were incubated with methadone (1 μm) C, The same experiment done with oxymorphone (1 μm) for 1 h. D, Summarized results plotting the ratio of ME2/ME1 in experiments using slices incubated in buprenorphine (BUP; 5 nm), etorphine (ET; 2 nm), oxymorphone (OM; 1 μm), oxycodone (OC; 1 μm), or methadone (MD; 1 μm) for 1 h before the experiment. There was a marked decrease in the ME current in all experiments except in slices incubated in buprenorphine. Yoh, Yohimbine.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Buprenorphine does not cause receptor internalization and blocked the internalization induced by ME. A, Images of cells in three experiments. Left, Images taken at the beginning of the experiment after incubating slices with M1 anti-Flag antibody without drugs (top 2 images) or β-CNA (10 nm, 1 h; bottom image). The top three images are a control experiment demonstrating the internalization of receptor evoked by ME (30 μm, 15 min). The fluorescence image on the right is only internalized receptors after treatment of the slice with a calcium-free solution to strip antibody bound to extracellular surface. Middle images show that buprenorphine (15 μm) did not induce any internalization. The bottom images show that treatment of slices with a low concentration of β-CNA reduced but did not abolish the ME-induced receptor internalization. Scale bar, 10 μm. B, Summarized results from several experiments showing the amount of internalization (fluorescence as a percentage of the control) induced by ME in control, after treatment of slices with β-CNA (10 nm, 1 h) or buprenorphine (Bup; 5 nm, 1 h). The open bar is the background fluorescence measured after treatment of the slices with calcium-free solution without application of any drug. *p < 0.05.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Chronic treatment of animals with buprenorphine. A, B, Representative experiments in slices taken from animals treated with a low (1 mg · kg−1 · d−1; A) or high (10 mg · kg−1 · d−1; B) dose of buprenorphine (BUP). A, In a slice taken from an animal treated with a low dose of buprenorphine (1 mg · kg−1 · d−1), desensitization and the recovery from desensitization is the same as that observed in untreated animals. B, Desensitization was completely blocked in slices taken from animals treated with a high dose. C, Summary of the peak current induced by ME (30 μm) in slices from control and buprenorphine-treated animals. D, Summary of the decline in the current induced by ME (30 μm) during a 10 min application. E, Summary of the recovery from desensitization induced by ME (30 μm, 10 min). The amount of recovery and the speed at which recovery occurred was increased in slices from buprenorphine-treated animals. The current induced by UK14304 (3 μm; UK) was reversed by the application of yohimbine (1 μm; YOH).

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • supplemental material - Supplemental Legend
    • supplemental material - Supplemental Figure
Back to top

In this issue

The Journal of Neuroscience: 29 (22)
Journal of Neuroscience
Vol. 29, Issue 22
3 Jun 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization
Michael S. Virk, Seksiri Arttamangkul, William T. Birdsong, John T. Williams
Journal of Neuroscience 3 June 2009, 29 (22) 7341-7348; DOI: 10.1523/JNEUROSCI.3723-08.2009

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization
Michael S. Virk, Seksiri Arttamangkul, William T. Birdsong, John T. Williams
Journal of Neuroscience 3 June 2009, 29 (22) 7341-7348; DOI: 10.1523/JNEUROSCI.3723-08.2009
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Cellular/Molecular

  • Acute ethanol modulates synaptic inhibition in the basolateral amygdala via rapid NLRP3 inflammasome activation and regulates anxiety-like behavior in rats
  • KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons
  • Tonic activation of NR2D-containing NMDARs exacerbates dopaminergic neuronal loss in MPTP-injected Parkinsonian mice
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.